Biocon Limited Q3 FY2022 Investor Presentation January 2022

Biocon Limited's Q3 FY2022 investor presentation from January 2022. The global biopharmaceutical company leverages its affordable innovation model to improve access to high-quality medicines and address gaps in scientific research to impact lives globally.